08 August 2019

HoloMed

User Interface Design: Keeping the User in Mind

mRay-Gestensteuerung im OP

mbits-partner UID cooperating in the joint project HoloMed, is currently working on the design of the future user interface. Due to a simple and safe application, that is adapted to the needs of the treating staff of neurosurgery, they aim an ideal support during the ventricular puncture. The UID has published a time lapse video of its work.
29 July 2019

Successful test of mRay gesture control

The Diakonissenkrankenhaus Mannheim is testing the contactless operation of mRay

mRay-Gestensteuerung im OP

Under the direction of Dr. med. Markus Bochhacker the Diakonissenkrankenhaus Mannheim successfully tested the touchless control of mRay under operating conditions. The aim of the gesture control is the intuitive, comfortable handling of our app under sterile conditions. The promising results of the test are now evaluated and published promptly. We will keep you up to date.
24 July 2019

mRay 5.8 is there

A new version of our app is now available. mRay 5.8 offers an improved reporting workflow, the possibility of an HL-7 connection and a freely configurable search. Besides some performance optimizations, the new version also includes a first update of the module mRay-VEOcore. The automated perfusion analysis with VEOcore 1.1 is more performant than before.

The update is now available for all systems (iOS, Android, Windows) in AppStore and Google Play. A current desktop version can be found at the following link: https://mbits.info/downloads/mray.

19 July 2019

UMG evaluated mRay

The University Medicine Göttingen comes to excellent results with their scientific examination of our mRay-App

UMG evaluates mRay with excellent results

Im Plos-Journal published the Universitätsmedizin Göttingen its scientific studies on mRay. Even though we already assumed this, the results are clear and we are very pleased: "Software solutions such as mRay for handheld devices provide adequate diagnostic quality". for the review of CT scans of suspected stroke patients." The authors of the study are Alex Brehm, Volker Maus, Eya Khadhraoui and Marios-Nikos Psychogios. You can view the complete paper here.

12 July 2019

mbits research project at HS Ulm

In cooperation with mbits new methods for stroke treatment are being researched at the HSU

In cooperation with mbits, new methods for stroke treatment are being researched at THU

mbits is a cooperative partner of the ThromboMap third-party funding project, which began in April and aims to develop new stroke treatment methods over a three-year period. With the help of a newly established research laboratory at the Technische Hochschule Ulm, doctoral students and several bachelor and master students are investigating new possibilities for the safe removal of blood clots in the brain. mbits supports the project with the know-how around our fully automated stroke evaluation mRay-VEOcore.

01 July 2019

mbits cooperates with Telepaxx

mbits at contract signing for a partnership with Telepaxx

mbits Partnership with Telepaxx

The storage service and medical archive company Telepaxx, based in Büchenbach near Nürnberg, is a new mbits partner. The managing directors of both companies recently signed a corresponding cooperation agreement. Our app mRay is now part of the Telepaxx MarketPlace. It provides solutions for start-ups and scientists to train and develop applications based on AI and Digital Health in a quality-assured and data protection-compliant environment. Telepaxx and mbits thus combine the competencies of two companies that complement each other excellently in the field of teleconsultation.

25 June 2019

New mbits customer in Hettstedt

Radiological Centre Mansfelder Land purchases mRay

mRay in Radiologie Magazin: Simply sent

We are pleased that we could convince the Radiologische Zentrum Mansfelder Land of mRay. The practice uses our app as referring physician portal to provide digital image data and findings. We would like to thank you very much for your trust.

 2019 mbits imaging GmbH, all rights reserved.

Deutsches Krebsforschungszentrum